No. of patients | |
---|---|
Total No. of patients | 32 |
< 5 years old | 13 |
≥ 5 years old | 19 |
Sex | |
Male | 19 |
Female | 13 |
Mean ± SD | |
Mean age (years) | 5 3 |
Mean age of diagnosis (months) | 14 15 |
Mean age of first blood transfusion (months) | 15 15 |
Mean age of the start of chelating therapy (years) | 3 2 |
No. of patients | |
Chelating regulatory (≥1 chelating agent) | |
Regular | 19 |
Only Deferoxamine | 0 |
Only Defriprone | 6 |
Only Deferasirox | 6 |
Deferoxamine+Defriprone | 4 |
Defriprone+Deferasirox | 2 |
Not regular | 1 |
Never | 12 |
No. of patients with oral supplementations (Calcium or Vitamin D) | |
Regular | 12 |
Occasional | 5 |
Never | 15 |